Section of General Thoracic Surgery, Division of Cardiothoracic Surgery, University of Colorado School of Medicine, C-310, 12631 East 17th Avenue, Aurora, CO 80045, USA.
Clin Chest Med. 2015 Mar;36(1):117-22. doi: 10.1016/j.ccm.2014.11.004. Epub 2014 Dec 19.
The incidence of pulmonary nontuberculous mycobacterial disease is increasing. Despite aggressive medical therapy, a subset of patients will experience treatment failure or suffer disabling or life-threatening symptoms. The use of anatomic lung resection in addition to optimal medical management may, in select cases, result in improved clinical outcomes. More data are needed to confirm this approach. For those with nontuberculous mycobacterial infection, treatment in a multidisciplinary setting including surgeons familiar with operative techniques specific to infectious lung disease will improve patient care.
非结核分枝杆菌肺病的发病率正在上升。尽管进行了积极的药物治疗,但仍有一部分患者会出现治疗失败或出现致残或危及生命的症状。在最佳药物治疗的基础上,采用解剖性肺切除术可能会改善某些情况下的临床结局,但需要更多的数据来证实这种方法。对于患有非结核分枝杆菌感染的患者,在包括熟悉针对感染性肺病的特定手术技术的外科医生的多学科治疗环境中进行治疗,将改善患者的护理。